跳至主要内容
临床试验/CTRI/2021/11/038154
CTRI/2021/11/038154已完成未知

To evaluate the Anti-grey efficacy of test regimen in healthy Indian human - None

nilever Industries Pvt Ltd0 个研究点目标入组 159 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
159

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Female and male subjects in the ratio of 2:1 in general good health.
  • 2.Subjects in the age group 18-42 years (both the ages inclusive).
  • 3.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
  • 4.Subjects willing to apply TP as per instruction and they will not use any other hair product during the study period
  • 5.Subjects willing to abide by and comply with the study protocol.
  • 6.Subjects who have not participated in a similar investigation in the past three months.
  • 7.Subjects who agree to refrain from using hair dye / hair colour /henna during the study period.
  • 8.Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration

排除标准

  • 1.Subjects who have undergone hair growth treatment within 3 months before screening into the study.
  • 2.Subject who are currently using henna.
  • 3.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
  • 4.Subjects (females) who are pregnant or lactating
  • 5.Subjects who have had hair transplant.
  • 6.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
  • 7.Chronic illness which may influence the cutaneous state.
  • 8.Subjects participating in other similar cosmetic or therapeutic trial within last three months
  • 9.Subjects who have history of alcoholism, smoking and/ or psychiatric disorder including trichotillomania.
  • 10.Menopausal female subjects as determined by medical history
  • 11.Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
  • 12.Subjects having allergic reaction for oil

研究者

发起方
nilever Industries Pvt Ltd

相似试验